Literature DB >> 18761968

Hepatitis C action plan for Scotland: phase II (May 2008-March 2011).

D Goldberg1, G Brown, S Hutchinson, J Dillon, A Taylor, G Howie, S Ahmed, K Roy, M King.   

Abstract

Mesh:

Year:  2008        PMID: 18761968     DOI: 10.2807/ese.13.21.18876-en

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


× No keyword cloud information.
  15 in total

1.  International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK.

Authors: 
Journal:  J Int AIDS Soc       Date:  2016-10-23       Impact factor: 5.396

2.  Restrictions for reimbursement of direct-acting antiviral treatment for hepatitis C virus infection in Canada: a descriptive study.

Authors:  Alison D Marshall; Sahar Saeed; Lisa Barrett; Curtis L Cooper; Carla Treloar; Julie Bruneau; Jordan J Feld; Lesley Gallagher; Marina B Klein; Mel Krajden; Naglaa H Shoukry; Lynn E Taylor; Jason Grebely
Journal:  CMAJ Open       Date:  2016-10-14

3.  Modelling the impact of a national scale-up of interventions on hepatitis C virus transmission among people who inject drugs in Scotland.

Authors:  Hannah Fraser; Christinah Mukandavire; Natasha K Martin; David Goldberg; Norah Palmateer; Alison Munro; Avril Taylor; Matthew Hickman; Sharon Hutchinson; Peter Vickerman
Journal:  Addiction       Date:  2018-07-10       Impact factor: 6.526

4.  The Second Canadian Symposium on hepatitis C virus: a call to action.

Authors:  Jason Grebely; Marc Bilodeau; Jordan J Feld; Julie Bruneau; Benedikt Fischer; Jennifer F Raven; Eve Roberts; Norma Choucha; Rob P Myers; Selena M Sagan; Joyce A Wilson; Frank Bialystok; D Lorne Tyrrell; Michael Houghton; Mel Krajden
Journal:  Can J Gastroenterol       Date:  2013-11       Impact factor: 3.522

5.  A matched comparison study of hepatitis C treatment outcomes in the prison and community setting, and an analysis of the impact of prison release or transfer during therapy.

Authors:  E J Aspinall; W Mitchell; J Schofield; A Cairns; S Lamond; P Bramley; S E Peters; H Valerio; J Tomnay; D J Goldberg; P R Mills; S T Barclay; A Fraser; J F Dillon; N K Martin; M Hickman; S J Hutchinson
Journal:  J Viral Hepat       Date:  2016-08-11       Impact factor: 3.728

6.  Optimal control of hepatitis C antiviral treatment programme delivery for prevention amongst a population of injecting drug users.

Authors:  Natasha K Martin; Ashley B Pitcher; Peter Vickerman; Anna Vassall; Matthew Hickman
Journal:  PLoS One       Date:  2011-08-11       Impact factor: 3.240

7.  Identification of hepatitis B and C screening and patient management guidelines and availability of training for chronic viral hepatitis among health professionals in six European countries: results of a semi-quantitative survey.

Authors:  Angela Bechini; Abby Falla; Amena Ahmad; Irene Veldhuijzen; Sara Boccalini; Barbara Porchia; Miriam Levi
Journal:  BMC Infect Dis       Date:  2015-08-19       Impact factor: 3.090

8.  The successful implementation of Scotland's Hepatitis C Action Plan: what can other European stakeholders learn from the experience? A Scottish voluntary sector perspective.

Authors:  Leon Wylie; Sharon Hutchinson; David Liddell; Nicola Rowan
Journal:  BMC Infect Dis       Date:  2014-09-19       Impact factor: 3.090

Review 9.  Hepatitis C virus infection epidemiology among people who inject drugs in Europe: a systematic review of data for scaling up treatment and prevention.

Authors:  Lucas Wiessing; Marica Ferri; Bart Grady; Maria Kantzanou; Ida Sperle; Katelyn J Cullen; Angelos Hatzakis; Maria Prins; Peter Vickerman; Jeffrey V Lazarus; Vivian D Hope; Catharina Matheï
Journal:  PLoS One       Date:  2014-07-28       Impact factor: 3.240

10.  Injecting drug users in Scotland, 2006: Listing, number, demography, and opiate-related death-rates.

Authors:  Ruth King; Sheila M Bird; Antony Overstall; Gordon Hay; Sharon J Hutchinson
Journal:  Addict Res Theory       Date:  2012-08-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.